Glycoengineering of Natural Killer Cells with CD22 Ligands for Enhanced Anticancer Immunotherapy.
Wang X, Lang S, Tian Y, Zhang J, Yan X, Fang Z, Weng J, Lu N, Wu X, Li T, Cao H, Li Z, Huang X.
Wang X, et al. Among authors: li t, li z.
ACS Cent Sci. 2020 Mar 25;6(3):382-389. doi: 10.1021/acscentsci.9b00956. Epub 2020 Mar 5.
ACS Cent Sci. 2020.
PMID: 32232138
Free PMC article.